Mind Medicine Inc (NASDAQ: MNMD) on Monday, plunged -13.45% from the previous trading day, before settling in for the closing price of $14.2. Within the past 52 weeks, MNMD’s price has moved between $4.70 and $14.43.
During the last 5-year period, the sales growth of Healthcare Sector giant was 12.11%. The company achieved an average annual earnings per share of -14.50%. With a float of $72.58 million, this company’s outstanding shares have now reached $75.80 million.
Mind Medicine Inc (MNMD) Breakdown of a Key Holders of the stock
Observing investor behavior towards Biotechnology industry stocks is more important than anything else. The insider ownership of Mind Medicine Inc is 3.94%, while institutional ownership is 54.34%. The most recent insider transaction that took place on Sep 25 ’25, was worth 110,186. In this transaction Chief Legal Officer of this company sold 11,278 shares at a rate of $9.77, taking the stock ownership to the 293,852 shares. Before that another transaction happened on Sep 25 ’25, when Company’s Chief Executive Officer sold 25,797 for $9.77, making the entire transaction worth $252,037. This insider now owns 804,268 shares in total.
Mind Medicine Inc (MNMD) Recent Fiscal highlights
As on 9/30/2024, Multinational firm has announced its last quarter scores, in which it reported -0.18 earnings per share (EPS) for the period topping the consensus outlook (set at -0.26) by 0.08. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.51 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -14.50% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will plunge by -3.97% during the next five years compared to 12.11% growth over the previous five years of trading.
Mind Medicine Inc (NASDAQ: MNMD) Trading Performance Indicators
Mind Medicine Inc (MNMD) is currently performing well based on its current performance indicators. A quick ratio of 4.98 was reported for the most recent quarter.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.46, a number that is poised to hit -0.50 in the next quarter and is forecasted to reach -1.81 in one year’s time.
Technical Analysis of Mind Medicine Inc (MNMD)
Looking closely at Mind Medicine Inc (NASDAQ: MNMD), its last 5-days average volume was 3.54 million, which is a jump from its year-to-date volume of 1.58 million. As of the previous 9 days, the stock’s Stochastic %D was 56.49%.
During the past 100 days, Mind Medicine Inc’s (MNMD) raw stochastic average was set at 73.55%, which indicates a significant increase from 25.44% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 1.01 in the past 14 days, which was higher than the 0.63 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $11.13, while its 200-day Moving Average is $8.33. However, in the short run, Mind Medicine Inc’s stock first resistance to watch stands at $13.63. Second resistance stands at $14.96. The third major resistance level sits at $15.73. If the price goes on to break the first support level at $11.53, it is likely to go to the next support level at $10.76. Now, if the price goes above the second support level, the third support stands at $9.43.
Mind Medicine Inc (NASDAQ: MNMD) Key Stats
Market capitalization of the company is 935.12 million based on 76,088K outstanding shares. Right now, sales total 0 K and income totals -108,680 K. The company made 0 K in profit during its latest quarter, and -42,740 K in sales during its previous quarter.
